At Sagittarius IP, we are a team of highly qualified individuals with a passion for helping our clients achieve maximum value from their intellectual property. Founded in 2002 by Andrew Teuten, we have grown to become one of the UK’s largest firms specialising in biotechnology, chemistry and pharmaceutical patents.

We pride ourselves on maintaining exceptionally high standards and continually exceeding our clients’ expectations. Drawing on extensive experience in the pharmaceutical industry, we provide commercially focused, proactive advice and a full range of patent services, including drafting and prosecution, IP portfolio management and due diligence reviews. Our clients range from start-ups, university spin-outs and academic research organisations to venture capital funds, small businesses and FTSE 100 companies.

Since 2019, we have been recognised in the Financial Times review of Europe’s leading patent law firms, and in 2025 we were awarded “Gold” ratings in the Chemistry & Pharmacy and Biotechnology, Food & Healthcare fields. Much of our work comes through recommendation, reflecting the strong, trusted relationships we build and the results we deliver.

At Sagittarius IP, our focus is always on helping clients protect, strengthen and maximise the value of their intellectual property, with advice that is both practical and commercially driven.